Assessment of Metabolic Fluxes by In Vivo MR Spectroscopy

Clinical Diabetes Research: Methods and Techniques

Volumn , Issue , 2007, Pages 193-222

  Krššák, Martin ^a   Roden, Michael ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Karl Landsteiner Institute for Endocrinology and Metabolism   (Austria)

Author keywords

Arterio venous isotope balance; Blood oxygenation level dependent; Free fatty acids; Insulin resistance and sensitivity; Resonance frequency; Skeletal muscle glycogen synthesis; Specific absorption rate; Superconductive magnets; Total hepatic glycogen; Type 2 diabetes mellitus

Indexed keywords

FATTY ACIDS; MAGNETIC RESONANCE SPECTROSCOPY;

BLOOD OXYGENATION LEVEL DEPENDENT; FREE FATTY ACID; INSULIN RESISTANCE; ISOTOPE BALANCE; RESONANCE FREQUENCIES; SKELETAL MUSCLE; SPECIFIC ABSORPTION RATE; TOTAL HEPATIC GLYCOGEN; TYPE 2 DIABETES MELLITUS;

MUSCLE;

EID: 55949105307     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470513095.ch11     Document Type: Chapter

References (140)

1. Anderwald, C, Bernroider, E, Krššák, M, Stingl, H, Brehm, A, Bischof, M G, Nowotny, P, Roden, M, Waldhausl, W (2002) Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle, Diabetes, 51, 10, 3025-3032.
2. Argov, Z, De Stefano, N, Arnold, D L (1996) ADP recovery after a brief ischemic exercise in normal and diseased human muscle-a 31P MRS study, NMR Biomed, 9, 4, 165-172.
3. Arnold, D L, Matthews, P M, Radda, G K (1984) Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR, Magn Reson Med, 1, 3, 307-315.
4. Beckmann, N, Fried, R, Turkalj, I, Seelig, J, Keller, U, Stalder, G (1993) Noninvasive observation of hepatic glycogen formation in man by 13C MRS after oral and intravenous glucose administration, Magn Reson Med, 29, 5, 583-590.
5. Bischof, M G, Bernroider, E, Krššák, M, Krebs, M, Stingl, H, Nowotny, P, Yu, C, Shulman, G I, Waldhausl, W, Roden, M (2002) Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia, Diabetes, 51, 1, 49-54.
6. Bischof, M G, Brehm, A, Bernroider, E, Krššák, M, Mlynarik, V, Krebs, M, Roden, M (2006) Cerebral glutamate metabolism during hypoglycaemia in healthy and type 1 diabetic humans, Eur J Clin Invest, 36, 3, 164-169.
7. Bischof, M G, Krššák, M, Krebs, M, Bernroider, E, Stingl, H, Waldhausl, W, Roden, M (2001) Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes, Diabetes, 50, 2, 392-398.
8. Bischof, M G, Mlynarik, V, Brehm, A, Bernroider, E, Krššák, M, Bauer, E, Madl, C, Bayerle-Eder, M, Waldhausl, W, Roden, M (2004) Brain energy metabolism during hypoglycaemia in healthy and type 1 diabetic subjects, Diabetologia, 47, 4, 648-651.
9. Bluml, S, Moreno, A, Hwang, J H, Ross, B D (2001) 1-(13)C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders, NMR Biomed, 14, 1, 19-32.
10. Bluml, S, Moreno-Torres, A, Ross, B D (2001) [1-13C]glucose MRS in chronic hepatic encephalopathy in man, Magn ResonMed, 45, 6, 981-993.
11. Bluml, S, Moreno-Torres, A, Shic, F, Nguy, C H, Ross, B D (2002) Tricarboxylic acid cycle of glia in the in vivo human brain, NMR Biomed, 15, 1, 1-5.
12. Borgs, M, Van Hecke, P, Overloop, K, Decanniere, C, Van Huffel, S, Stalmans, W, Vanstapel, F (1993) In situ 13C NMR quantification of hepatic glycogen, NMR Biomed, 6, 6, 371-376.
13. Brehm, A, Krššák, M, Schmid, A I, Nowotny, P, Waldhausl, W, Roden, M (2006) Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle, Diabetes, 55, 1, 136-140.
14. Bruce, C R, Anderson, M J, Carey, A L, Newman, D G, Bonen, A, Kriketos, A D, Cooney, G J, Hawley, J A (2003) Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status, J Clin Endocrinol Metab, 88, 11, 5444-5451.
15. Carey, P E, Halliday, J, Snaar, J E, Morris, P G, Taylor, R (2003) Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects, Am J Physiol Endocrinol Metab, 284, 4, E688-E694.
16. Chen, W, Zhu, X H, Gruetter, R, Seaquist, E R, Adriany, G, Ugurbil, K (2001) Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using (1)H-[(13)C] MRS and fMRI, Magn Reson Med, 45, 3, 349-355.
17. Chhina, N, Kuestermann, E, Halliday, J, Simpson, L J, Macdonald, I A, Bachelard, H S, Morris, P G (2001) Measurement of human tricarboxylic acid cycle rates during visual activation by (13)C magnetic resonance spectroscopy, J Neurosci Res, 66, 5, 737-746.
18. Choi, I Y Gruetter, R (2003) In vivo 13C NMR assessment of brain glycogen concentration and turnover in the awake rat, Neurochem Int, 43, 4-5, 317-322.
19. Choi, I Y, Lee, S P, Kim, S G, Gruetter, R (2001) In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia, J Cereb Blood Flow Metab, 21, 6, 653-663.
20. Choi, I Y, Seaquist, E R, Gruetter, R (2003) Effect of hypoglycemia on brain glycogen metabolism in vivo, J Neurosci Res, 72, 1, 25-32.
21. Choi, I Y, Tkac, I, Gruetter, R (2000) Single-shot, three-dimensional non-echo localization method for in vivo NMR spectroscopy, Magn Reson Med, 44, 3, 387-394.
22. Choi, I Y, Tkac, I, Ugurbil, K, Gruetter, R (1999) Noninvasive measurements of [1-(13)C]glycogen concentrations and metabolism in rat brain in vivo, J Neurochem, 73, 3, 1300-1308.
23. Cline, G W, Jucker, B M, Trajanoski, Z, Rennings, A J, Shulman, G I (1998) A novel 13C NMR method to assess intracellular glucose concentration in muscle, in vivo, Am J Physiol, 274, 2 Pt 1, E381-E389.
24. Cline, G W, Petersen, K F, Krššák, M, Shen, J, Hundal, R S, Trajanoski, Z, Inzucchi, S, Dresner, A, Rothman, D L, Shulman, G I (1999) Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes, N Engl J Med, 341, 4, 240-246.
25. Consoli, A, Kennedy, F, Miles, J, Gerich, J (1987) Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man, J Clin Invest, 80, 5, 1303-1310.
26. Criego, A B, Tkac, I, Kumar, A, Thomas, W, Gruetter, R, Seaquist, E R (2005a) Brain glucose concentrations in healthy humans subjected to recurrent hypoglycemia, J Neurosci Res, 82, 4, 525-530.
27. Criego, A B, Tkac, I, Kumar, A, Thomas, W, Gruetter, R, Seaquist, E R (2005b) Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness, J Neurosci Res, 79, 1-2, 42-47.
28. de Graaf, R A, Mason, G F, Patel, A B, Behar, K L, Rothman, D L (2003) In vivo 1H-[13C]-NMR spectroscopy of cerebral metabolism, NMR Biomed, 16, 6-7, 339-357.
29. Defronzo, R A (1988) Lilly lecture 1987 The triumvirate: beta-cell, muscle, liver A collusion responsible for NIDDM, Diabetes, 37, 6, 667-687.
30. Delmas-Beauvieux, M C, Quesson, B, Thiaudiere, E, Gallis, J L, Canioni, P, Gin, H (1999) 13C nuclear magnetic resonance study of glycogen resynthesis in muscle after glycogen-depleting exercise in healthy men receiving an infusion of lipid emulsion, Diabetes, 48, 2, 327-333.
31. Dresner, A, Laurent, D, Marcucci, M, Griffin, M E, Dufour, S, Cline, G W, Slezak, L A, Andersen, D K, Hundal, R S, Rothman, D L, Petersen, K F, Shulman, G I (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity, J Clin Invest, 103, 2, 253-259.
32. Ellis, B A, Poynten, A, Lowy, A J, Furler, S M, Chisholm, D J, Kraegen, E W, Cooney, G J (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle, Am J Physiol Endocrinol Metab, 279, 3, pp E554-E560.
33. Faergeman, N J Knudsen, J (1997) Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling, BiochemJ, 323 (Pt 1), 1-12.
34. Felig, P, Marliss, E, Cahill, G F, Jr (1969) Plasma amiacid levels and insulin secretion in obesity, N Engl J Med, 281, 15, 811-816.
35. Firth, R G, Bell, P M, Marsh, H M, Hansen, I, Rizza, R A (1986) Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus Role of hepatic and extrahepatic tissues, J Clin Invest, 77, 5, 1525-1532.
36. Freeman, R (2003) Magnetic resonance in chemistry and medicine, first edn, Oxford University Press Inc, New York.
37. Gadian, D G (1995) NMR and its applications to living systems Oxford University Press Inc, New York.
38. Gan, S K, Kriketos, A D, Ellis, B A, Thompson, C H, Kraegen, E W, Chisholm, D J (2003) Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men, Diabetes Care, 26, 6, 1706-1713.
39. Goodpaster, B H, Katsiaras, A, Kelley, D E (2003) Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity, Diabetes, 52, 9, 2191-2197.
40. Griffin, M E, Marcucci, M J, Cline, G W, Bell, K, Barucci, N, Lee, D, Goodyear, L J, Kraegen, E W, White, M F, Shulman, G I (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade, Diabetes, 48, 6, 1270-1274.
41. Gruetter, R, Adriany, G, Choi, I Y, Henry, P G, Lei, H, Oz, G (2003) Localized in vivo 13C NMR spectroscopy of the brain, NMR Bio med, 16, 6-7, 313-338.
42. Gruetter, R, Magnusson, I, Rothman, D L, Avison, M J, Shulman, R G, Shulman, GI (1994) Validation of 13C NMR measurements of liver glycogen in vivo, Magn Reson Med, 31, 6, 583-588.
43. Gruetter, R, Prolla, T A, Shulman, R G (1991) 13C NMR visibility of rabbit muscle glycogen in vivo, Magn Reson Med, 20, 2, 327-332.
44. Gruetter, R, Seaquist, E R, Ugurbil, K (2001) A mathematical model of compartmentalized neurotransmitter metabolism in the human brain, Am J Physiol Endocrinol Metab, 281, 1, E100-E112.
45. Gruetter, R, Ugurbil, K, Seaquist, E R (1998) Steady-state cerebral glucose concentrations and transport in the human brain, J Neurochem, 70, 1, 397-408.
46. Hundal, R S, Krššák, M, Dufour, S, Laurent, D, Lebon, V, Chandramouli, V, Inzucchi, S E, Schumann, W C, Petersen, K F, Landau, B R, Shulman, G I (2000) Mechanism by which metformin reduces glucose production in type 2 diabetes, Diabetes, 49, 12, 2063-2069.
47. Hwang, J H, Perseghin, G, Rothman, D L, Cline, G W, Magnusson, I, Petersen, K F, Shulman, G I (1995) Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion A 13C nuclear magnetic resonance spectroscopy study, J Clin Invest, 95, 2, 783-787.
48. Jacob, S, Machann, J, Rett, K, Brechtel, K, Volk, A, Renn, W, Maerker, E, Matthaei, S, Schick, F, Claussen, C D, Haring, H U (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects, Diabetes, 48, 5, 1113-1119.
49. Jue, T, Rothman, D L, Shulman, G I, Tavitian, B A, Defronzo, R A, Shulman, R G (1989) Direct observation of glycogen synthesis in human muscle with 13C NMR, Proc Natl Acad Sci USA, 86, 12, 4489-4491.
50. Kacser, H Burns, J A (1973) The control of flux, Symp Soc Exp Biol, 27, 65-104.
51. Katz, L D, Glickman, M G, Rapoport, S, Ferrannini, E, Defronzo, R A (1983) Splanchnic and peripheral disposal of oral glucose in man, Diabetes, 32, 7, 675-679.
52. Kelley, D E, He, J, Menshikova, E V, Ritov, V B (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes, Diabetes, 51, 10, 2944-2950.
53. Kemp, G J Radda, G K (1994) Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: an analytical review, Magn Reson Q, 10, 1, 43-63.
54. Kishore, P, Gabriely, I, Cui, M H, Di Vito, J, Gajavelli, S, Hwang, J H, Shamoon, H (2006) Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes, Diabetes, 55, 3, 659-666.
55. Krebs, M, Brehm, A, Krššák, M, Anderwald, C, Bernroider, E, Nowotny, P, Roth, E, Chandramouli, V, Landau, B R, Waldhausl, W, Roden, M (2003) Direct and indirect effects of amiacids on hepatic glucose metabolism in humans, Diabetologia, 46, 7, 917-925.
56. Krebs, M, Krššák, M, Bernroider, E, Anderwald, C, Brehm, A, Meyerspeer, M, Nowotny, P, Roth, E, Waldhausl, W, Roden, M (2002) Mechanism of amiacid-induced skeletal muscle insulin resistance in humans, Diabetes, 51, 3, 599-605.
57. Krebs, M, Krššák, M, Nowotny, P, Weghuber, D, Gruber, S, Mlynarik, V, Bischof, M, Stingl, H, Furnsinn, C, Waldhausl, W, Roden, M (2001) Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans, J Clin Endocrinol Metab, 86, 5, 2153-2160.
58. Krššák, M, Brehm, A, Bernroider, E, Anderwald, C, Nowotny, P, Dalla, M C, Cobelli, C, Cline, G W, Shulman, G I, Waldhausl, W, Roden, M (2004) Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes, Diabetes, 53, 12, 3048-3056.
59. Krššák, M, Falk, P K, Dresner, A, DiPietro, L, Vogel, S M, Rothman, D L, Roden, M, Shulman, G I (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study, Diabetologia, 42, 1, 113-116.
60. Krššák, M Roden, M (2004) The role of lipid accumulation in liver and muscle for insulin resistance and type 2 diabetes mellitus in humans, Rev Endocr Metab Disord, 5, 2, 127-134.
61. Larson-Meyer, D E, Heilbronn, L K, Redman, L M, Newcomer, B R, Frisard, M I, Anton, S, Smith, S R, Alfonso, A, Ravussin, E (2006) Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects, Diabetes Care, 29, 6, 1337-1344.
62. Larson-Meyer, D E, Newcomer, B R, Hunter, G R, McLean, J E, Hetherington, H P, Weinsier, R L (2000) Effect of weight reduction, obesity predisposition, and aerobic fitness on skeletal muscle mitochondrial function, Am J Physiol Endocrinol Metab, 278, 1, p E153-E161.
63. Lebon, V, Petersen, K F, Cline, G W, Shen, J, Mason, G F, Dufour, S, Behar, K L, Shulman, G I, Rothman, D L (2002) Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism, J Neurosci, 22, 5, 1523-1531.
64. Linn, T, Santosa, B, Gronemeyer, D, Aygen, S, Scholz, N, Busch, M, Bretzel, R G (2000) Effect of long-term dietary protein intake on glucose metabolism in humans, Diabetologia, 43, 10, 1257-1265.
65. Magnusson, I, Rothman, D L, Jucker, B, Cline, G W, Shulman, R G, Shulman, G I (1994) Liver glycogen turnover in fed and fasted humans, Am J Physiol, 266, 5 Pt 1, p E796-E803.
66. Mason, G F, Falk, P K, de Graaf, R A, Kanamatsu, T, Otsuki, T, Shulman, G I, Rothman, D L (2003) A comparison of (13)C NMR measurements of the rates of glutamine synthesis and the tricarboxylic acid cycle during oral and intravenous administration of [1-(13)C]glucose, Brain Res Brain Res Protoc, 10, 3, 181-190.
67. Mason, G F, Pan, J W, Chu, W J, Newcomer, B R, Zhang, Y, Orr, R, Hetherington, H P (1999) Measurement of the tricarboxylic acid cycle rate in human grey and white matter in vivo by 1H-[13C] magnetic resonance spectroscopy at 41T, J Cereb Blood Flow Metab, 19, 11, 1179-1188.
68. Menshikova, E V, Ritov, V B, Fairfull, L, Ferrell, R E, Kelley, D E, Goodpaster, B H (2006) Effects of exercise on mitochondrial content and function in aging human skeletal muscle, J Gerontol A Biol Sci Med Sci, 61, 6, 534-540.
69. Menshikova, E V, Ritov, V B, Toledo, F G, Ferrell, R E, Goodpaster, B H, Kelley, D E (2005) Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity, Am J Physiol Endocrinol Metab, 288, 4, E818-E825.
70. Mierisova, S Ala-Korpela, M (2001) MR spectroscopy quantitation: a review of frequency domain methods, NMR Biomed, 14, 4, 247-259.
71. Mierisova, S, van den, B A, Tkac, I, Van Hecke, P, Vanhamme, L, Liptaj, T (1998) New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES, NMR Biomed, 11, 1, 32-39.
72. Moreno, A, Bluml, S, Hwang, J H, Ross, B D (2001) Alternative 1-(13)C glucose infusion protocols for clinical (13)C MRS examinations of the brain, Magn Reson Med, 46, 1, 39-48.
73. Morgenthaler, F D, Koski, D M, Kraftsik, R, Henry, P G, Gruetter, R (2006) Biochemical quantification of total brain glycogen concentration in rats under different glycemic states, Neurochem Int, 48, 6-7, 616-622.
74. Newcomer, B R Boska, M D (1997) Adenosine triphosphate production rates, metabolic economy calculations, pH, phosphomonoesters, phosphodiesters, and force output during short-duration maximal isometric plantar flexion exercises and repeated maximal isometric plantar flexion exercises, Muscle Nerve, 20, 3, 336-346.
75. Newcomer, B R, Larson-Meyer, D E, Hunter, G R, Weinsier, R L (2001) Skeletal muscle metabolism in overweight and post-overweight women: an isometric exercise study using (31)P magnetic resonance spectroscopy, Int J Obes Relat Metab Disord, 25, 9, 1309-1315.
76. Nilsson, L H, Furst, P, Hultman, E (1973) Carbohydrate metabolism of the liver in normal man under varying dietary conditions, Scand J Clin Lab Invest, 32, 4, 331-337.
77. Nilsson, L H Hultman, E (1973) Liver glycogen in man-the effect of total starvation or a carbohydrate-poor diet followed by carbohydrate refeeding, Scand J Clin Lab Invest, 32, 4, 325-330.
78. Overloop, K, Vanstapel, F, Van Hecke, P (1996) 13C-NMR relaxation in glycogen, Magn Reson Med, 36, 1, 45-51.
79. Oz, G, Seaquist, E R, Kumar, A, Criego, A B, Benedict, L E, Rao, J P, Henry, P G, Van de Moortele, P F, Gruetter, R (2006) Human Brain Glycogen Content and Metabolism: Implications on its Role in Brain Energy Metabolism, Am J Physiol Endocrinol Metab.
80. Pan, J W, de Graaf, R A, Petersen, K F, Shulman, G I, Hetherington, H P, Rothman, D L (2002) [2, 4-13 C2]-beta-Hydroxybutyrate metabolism in human brain, J Cereb Blood Flow Metab, 22, 7, 890-898.
81. Pasquier, F, Boulogne, A, Leys, D, Fontaine, P (2006) Diabetes mellitus and dementia, Diabetes Metab, 32, 5 Pt 1, 403-414.
82. Perseghin, G, Price, T B, Petersen, K F, Roden, M, Cline, G W, Gerow, K, Rothman, D L, Shulman, GI (1996) Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects, N Engl J Med, 335, 18, 1357-1362.
83. Perseghin, G, Scifo, P, De Cobelli, F, Pagliato, E, Battezzati, A, Arcelloni, C, Vanzulli, A, Testolin, G, Pozza, G, Del Maschio, A, Luzi, L (1999) Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents, Diabetes, 48, 8, 1600-1606.
84. Petersen, K F, Befroy, D, Dufour, S, Dziura, J, Ariyan, C, Rothman, D L, DiPietro, L, Cline, G W, Shulman, G I (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 5622, 1140-1142.
85. Petersen, K F, Dufour, S, Befroy, D, Garcia, R, Shulman, G I (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, N Engl J Med, 350, 7, 664-671.
86. Petersen, K F, Dufour, S, Shulman, G I (2005) Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents, PLoS Med, 2, 9, E233.
87. Petersen, K F, Hendler, R, Price, T, Perseghin, G, Rothman, D L, Held, N, Amatruda, J M, Shulman, G I (1998a) 13C/31P NMR studies on the mechanism of insulin resistance in obesity, Diabetes, 47, 3, 381-386.
88. Petersen, K F, Krššák, M, Inzucchi, S, Cline, G W, Dufour, S, Shulman, G I (2000) Mechanism of troglitazone action in type 2 diabetes, Diabetes, 49, 5, 827-831.
89. Petersen, K F, Krššák, M, Navarro, V, Chandramouli, V, Hundal, R, Schumann, W C, Landau, B R, Shulman, G I (1999) Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis, Am J Physiol, 276, 3 Pt 1, p E529-E535.
90. Petersen, K F, Laurent, D, Rothman, D L, Cline, G W, Shulman, G I (1998b) Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans, J Clin Invest, 101, 6, 1203-1209.
91. Petersen, K F, Laurent, D, Yu, C, Cline, G W, Shulman, G I (2001) Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans, Diabetes, 50, 6, 1263-1268.
92. Price, T B, Perseghin, G, Duleba, A, Chen, W, Chase, J, Rothman, D L, Shulman, R G, Shulman, G I (1996) NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise, Proc Natl Acad Sci USA, 93, 11, 5329-5334.
93. Provencher, S W (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra, Magn Reson Med, 30, 6, 672-679.
94. Provencher, S W (2001) Automatic quantitation of localized in vivo 1H spectra with LCModel, NMR Bio med, 14, 4, 260-264.
95. Radda, GK, Odoom, J, Kemp, G, Taylor, DJ, Thompson, C, Styles, P (1995) Assessment of mitochondrial function and control in normal and diseased states, Biochim Biophys Acta, 1271, 1, 15-19.
96. Radziuk, J, McDonald, T J, Rubenstein, D, Dupre, J (1978) Initial splanchnic extraction of ingested glucose in normal man, Metabolism, 27, 6, 657-669.
97. Randle, P J, Garland, P B, Hales, C N, Newsholme, E A (1963) The glucose fatty-acid cycle Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet, 1, 785-789.
98. Ritov, V B, Menshikova, E V, He, J, Ferrell, R E, Goodpaster, B H, Kelley, D E (2005) Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes, Diabetes, 54, 1, 8-14.
99. Rizza, R A, Mandarino, L J, Gerich, J E (1981) Dose-response characteristics for effects of insulin on production and utilization of glucose in man, Am J Physiol, 240, 6, E630-E639.
100. Roden, M, Krššák, M, Stingl, H, Gruber, S, Hofer, A, Furnsinn, C, Moser, E, Waldhausl, W (1999) Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans, Diabetes, 48, 2, 358-364.
101. Roden, M, Perseghin, G, Petersen, K F, Hwang, J H, Cline, G W, Gerow, K, Rothman, D L, Shulman, G I (1996a) The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans, J Clin Invest, 97, 3, 642-648.
102. Roden, M, Price, T B, Perseghin, G, Petersen, K F, Rothman, D L, Cline, G W, Shulman, G I (1996b) Mechanism of free fatty acid-induced insulin resistance in humans, J Clin Invest, 97, 12, 2859-2865.
103. Roden, M, Stingl, H, Chandramouli, V, Schumann, W C, Hofer, A, Landau, B R, Nowotny, P, Waldhausl, W, Shulman, GI (2000) Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans, Diabetes, 49, 5, 701-707.
104. Rosenthal, J M, Amiel, S A, Yaguez, L, Bullmore, E, Hopkins, D, Evans, M, Pernet, A, Reid, H, Giampietro, V, Andrew, C M, Suckling, J, Simmons, A, Williams, S C (2001) The effect of acute hypoglycemia on brain function and activation: a functional magnetic resonance imaging study, Diabetes, 50, 7, 1618-1626.
105. Rothman, D L (2001) Studies of metabolic compartmentation and glucose transport using in vivo MRS, NMR Bio med, 14, 2, 149-160.
106. Rothman, D L, Magnusson, I, Cline, G, Gerard, D, Kahn, C R, Shulman, R G, Shulman, G I (1995) Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus, Proc Natl Acad Sci USA, 92, 4, 983-987.
107. Rothman, D L, Magnusson, I, Katz, L D, Shulman, R G, Shulman, G I (1991) Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR, Science, 254, 5031, 573-576.
108. Rothman, D L, Shulman, R G, Shulman, G I (1991) Nmr studies of muscle glycogen synthesis in normal and non-insulin-dependent diabetic subjects, Bio Chem Soc Trans, 19, 4, 992-994.
109. Rothman, D L, Shulman, R G, Shulman, G I (1992) 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus, J Clin Invest, 89, 4, 1069-1075.
110. Roussel, R, Carlier, P G, Robert, J J, Velho, G, Bloch, G (1998) 13C/31P NMR studies of glucose transport in human skeletal muscle, Proc Natl Acad Sci USA, 95, 3, 1313-1318.
111. Roussel, R, Carlier, P G, Wary, C, Velho, G, Bloch, G (1997) Evidence for 100 % 13C NMR visibility of glucose in human skeletal muscle, Magn Reson Med, 37, 6, 821-824.
112. Roussel, R, Velho, G, Carlier, P G, Jouvensal, L, Bloch, G (1996) In vivo NMR evidence for moderate glucose accumulation in human skeletal muscle during hyperglycemia, Am J Physiol, 271, 3 Pt 1, E434-E438.
113. Scheuermann-Freestone, M, Madsen, P L, Manners, D, Blamire, A M, Buckingham, R E, Styles, P, Radda, G K, Neubauer, S, Clarke, K (2003) Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes, Circulation, 107, 24, 3040-3046.
114. Seaquist, E R, Damberg, G S, Tkac, I, Gruetter, R (2001) The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans, Diabetes, 50, 10, 2203-2209.
115. Serlie, M J, De Haan, J H, Tack, C J, Verberne, H J, Ackermans, M T, Heerschap, A, Sauerwein, H P (2005) Glycogen synthesis in human gastrocnemius muscle is not representative of whole-body muscle glycogen synthesis, Diabetes, 54, 5, 1277-1282.
116. Shen, J, Petersen, K F, Behar, K L, Brown, P, Nixon, T W, Mason, G F, Petroff, O A, Shulman, G I, Shulman, R G, Rothman, D L (1999) Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR, Proc Natl Acad Sci USA, 96, 14, 8235-8240.
117. Shulman, GI (1999) Cellular mechanisms of insulin resistance in humans, Am J Cardiol, 84, 1A, 3J-10J.
118. Shulman, G I, Rothman, D L, Chung, Y, Rossetti, L, Petit, W A, Jr, Barrett, E J, Shulman, R G (1988) 13C NMR studies of glycogen turnover in the perfused rat liver, J Biol Chem, 263, 11, 5027-5029.
119. Shulman, G I, Rothman, D L, Jue, T, Stein, P, Defronzo, R A, Shulman, R G (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med, 322, 4, 223-228.
120. Shulman, R G (1996) Nuclear magnetic resonance studies of glucose metabolism in non-insulin-dependent diabetes mellitus subjects, Mol Med, 2, 5, 533-540.
121. Shulman, R G, Rothman, D L, Behar, K L, Hyder, F (2004) Energetic basis of brain activity: implications for neuroimaging, Trends Neurosci, 27, 8, 489-495.
122. Siesjo, B K (1978) Brain energy metabolism Wiley, New York.
123. Singhal, P, Caumo, A, Carey, P E, Cobelli, C, Taylor, R (2002) Regulation of endogenous glucose production after a mixed meal in type 2 diabetes, Am J Physiol Endocrinol Metab, 283, 2, E275-E283.
124. Sinha, R, Dufour, S, Petersen, K F, Lebon, V, Enoksson, S, Ma, Y Z, Savoye, M, Rothman, D L, Shulman, G I, Caprio, S (2002) Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity, Diabetes, 51, 4, 1022-1027.
125. Sirikul, B, Gower, B A, Hunter, G R, Larson-Meyer, D E, Newcomer, B R (2006) Relationship between insulin sensitivity and in vivo mitochondrial function in skeletal muscle, Am J Physiol Endocrinol Metab, 291, 4, E724-E728.
126. Stewart, R Liolitsa, D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia, Diabet Med, 16, 2, 93-112.
127. Stingl, H, Krššák, M, Krebs, M, Bischof, M G, Nowotny, P, Furnsinn, C, Shulman, G I, Wald-hausl, W, Roden, M (2001) Lipid-dependent control of hepatic glycogen stores in healthy humans, Diabetologia, 44, 1, 48-54.
128. Taylor, R, Magnusson, I, Rothman, D L, Cline, G W, Caumo, A, Cobelli, C, Shulman, G I (1996) Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects, J Clin Invest, 97, 1, 126-132.
129. Taylor, R, Price, T B, Rothman, D L, Shulman, R G, Shulman, G I (1992) Validation of 13C NMR measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples, Magn Reson Med, 27, 1, 13-20.
130. Thamer, C, Machann, J, Bachmann, O, Haap, M, Dahl, D, Wietek, B, Tschritter, O, Niess, A, Brechtel, K, Fritsche, A, Claussen, C, Jacob, S, Schick, F, Haring, H U, Stumvoll, M (2003) Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity, J Clin Endocrinol Metab, 88, 4, 1785-1791.
131. Tippett, P S Neet, K E (1982) An allosteric model for the inhibition of glucokinase by long chain acyl coenzyme A, J Biol Chem, 257, 21, 12846-12852.
132. Tremblay, F, Krebs, M, Dombrowski, L, Brehm, A, Bernroider, E, Roth, E, Nowotny, P, Waldhausl, W, Marette, A, Roden, M (2005) Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amiacid availability, Diabetes, 54, 9, 2674-2684.
133. Van Den Bergh, A J, Tack, C J, Van Den Boogert, H J, Vervoort, G, Smits, P, Heerschap, A (2000) Assessment of human muscle glycogen synthesis and total glucose content by in vivo 13C MRS, Eur J Clin Invest, 30, 2, 122-128.
134. Vanhamme, L, van den, B A, Van Huffel, S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge, J Magn Reson, 129, 1, 35-43.
135. Vanhamme, L, Van Huffel, S, Van Hecke, P, van Ormondt, D (1999) Time-domain quantification of series of biomedical magnetic resonance spectroscopy signals, J Magn Reson, 140, 1, 120-130.
136. Velho, G, Petersen, K F, Perseghin, G, Hwang, J H, Rothman, D L, Pueyo, M E, Cline, G W, Froguel, P, Shulman, G I (1996) Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects, J Clin Invest, 98, 8, 1755-1761.
137. Wahren, J, Felig, P, Cerasi, E, Luft, R (1972) Splanchnic and peripheral glucose and amiacid metabolism in diabetes mellitus, J Clin Invest, 51, 7, 1870-1878.
138. Wessels, A M, Rombouts, S A, Simsek, S, Kuijer, J P, Kostense, P J, Barkhof, F, Scheltens, P, Snoek, F J, Heine, R J (2006) Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study, Diabetes, 55, 2, 334-340.
139. Wititsuwannakul, D Kim, K H (1977) Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase, J Biol Chem, 252, 21, 7812-7817.
140. Zang, L H, Laughlin, M R, Rothman, D L, Shulman, R G (1990) 13C NMR relaxation times of hepatic glycogen in vitro and in vivo, Biochemistry, 29, 29, 6815-6820.